Translating faster results and automation into improved efficiency and cost savings is the cornerstone of your business case. Sources of value derived from use of the Growth Direct System, a rapid, automated, and non-destructive microbial enumeration test include quantifiable financial benefit resulting from:

• Improved Cycle time, faster release of in-process or final product.
• Inventory - Lowers product inventory to reduce working capital (in-process and/or final).
• Reduced in-process or final product scrap.
• Labor savings - QC, RA, QA, and/or production labor which can be redeployed or taken as savings.
• Increasing production capacity and/or amount of saleable product.

In addition strategic and operational benefits are important in building a business case including:

• Competitive advantage due to faster release, lower COGS, higher capacity, for example.
• Improving quality, compliance and facilitating major operational improvements such as Quality by Design (QbD), Lean Lab, and Process Analytical Technology (PAT)
• Automating the laboratory greatly enhancing operational efficiency of Micro QC organizations.
• Congruency with existing compendial methods - for instance non-destructive - enabling  improvements and validation with minimal unnecessary upheaval in SOPs, specifications, or issues with problem resolution.